Advances In Breast Cancer And Therapy

Advances in Breast Cancer and Therapy is an open access journal covers various aspects related to promote, share, and discuss various new issues towards development in breast cancer related problems by involving doctors, surgeons, and oncologist who are mostly passionate towards breast cancer research. The journal is highly oriented in giving emphasis is on the current updates along with recent scientific developments in all areas related to breast cancer and its treatment.

Focus and Scope

The objective of the journal is to maintain and develop science and related research at an international level towards breast cancer as major problems faced by aged women. In order to achieve this, it is important to bring into clinical research and mechanistic approaches, drug sensitivity and resistance, gene and antisense therapy, pathology, markers applied in curing this cancer form.

Breast Cancer Research and Therapy is a scientific journal which covers high quality manuscripts which are both relevant and applicable to the broad field of diseases and treatment. This journal encompasses the study full spectrum of biology and medicine relevant to breast cancer, with a special emphasis on the genetic, biochemical and cellular basis of breast cancer and allied therapy.

Indexing & Abstracting

All published articles are assigned to Digital Object Identifier (DOI) – Crossref.

All published articles of this journal are included in the indexing and abstracting coverage of:

•    Genamics – JournalSeek

•    Academic Keys

•    ResearchBib - Academic Research Index

•    Free Medical Journals - Geneva Foundation for Medical Education and Research

•    International Innovative Journal Impact Factor (IIJIF)

•    Al-Azhar University

•    Open J-Gate

•    Directory of Journals indexing

All published articles are permanently archived and available at Gavin Publishers website in HTML and PDF formats.

Note: This is a Peer-Reviewed Open Access Journal. All articles submitted to this journal will be published under the Attribution-ShareAlike CC BY-SA: Creative Commons Attribution-ShareAlike 4.0 International License. With this license, readers can share, distribute, download, and even use the content for commercial purposes, as long as the original source is properly cited. (*) denotes the Internal Impact Factor calculated by our EB experts.